MONTGOMERY, ALA. - Jere Beasley, founding shareholder of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., who is representing the State of Alabama in a series of cases against pharmaceutical companies accused of defrauding the state Medicaid system, will hold a news conference tomorrow, July 3, 2008, at 10 a.m. CT to address important developments in the remaining 69 cases.

An attorney for Alabama asked jurors Monday to award the state as much as $800 million from two pharmaceutical companies accused of overcharging for Medicaid drugs. The state claims GlaxoSmithKline and Novartis engaged in fraud from 1991 to 2005, depriving the cash-strapped Medicaid program of badly needed resources. Attorneys for the two firms said the companies followed federal rules and the prices were proper.

MONTGOMERY, ALA. - After a week of testimony and two days of deliberations, an Alabama jury today returned a verdict of $80.9 million against pharmaceutical company GlaxoSmithKline and $33.2 million against Novartis. The companies were accused of illegally overcharging the State of Alabama for Medicaid drugs.

The jury reached a decision Tuesday afternoon in the fraud lawsuit brought by the state against two drug companies. The jury awarded the state a little more than $33,000,000 in compensatory damages from Novartis Pharmaceutical Company and almost $81,000,000 in compensatory damages from GlaxoSmithKline also known as GSK.

(MONTGOMERY)-Attorney General Troy King today announced a second major victory in his litigation against drug companies for massive overcharges to the Alabama Medicaid Agency.  A jury in Montgomery County Circuit Court returned a verdict in favor of the State of Alabama, finding defendants, GlaxoSmithKline and Novartis Pharmaceuticals Corp. liable for a total of $114,247,233, of which $80,989,539 is from GlaxoSmithKline and $33,257,694 is from Novartis.

Lawsuits filed in federal and state court by several residents living near a yeast plant north of Headland claim the noxious odor coming from the plant is such a nuisance that it disrupts their quality of life, and are asking the court to award damages in their favor.

Dee Miles, who joined Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., in 1991, recently was selected by the American Trial Lawyers Association as one of the Top 100 Trial Lawyers in America. The ATLA is a national organization composed of the Top 100 Trial Lawyers from each state, with membership extended by special invitation only to those attorneys who exemplify superior qualifications, leadership, reputation, influence, stature, and profile, both civil plaintiff and criminal defense.

A judge in Montgomery has upheld the fraud verdict Alabama won against AstraZeneca Pharmaceuticals. But he trimmed the damages judgment from $215 million to $160 million.

Jere Beasley, founding shareholder of Montgomery, Alabama-based Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., has once again been recognized as one of the most outstanding lawyers in the United States. He was selected as one of 10 attorneys featured in The National Law Journal's 2008 special report, titled Winning: Successful strategies from some of the nation's top litigators.

On May 18, 2008 at the Montgomery Zoo, Beasley Allen will be taking steps to help cure Cystic Fibrosis.